Related references
Note: Only part of the references are listed.Life Expectancy, Standardized Mortality Ratios, and Causes of Death in Six Rheumatic Diseases in Hong Kong, China
C. C. Mok et al.
ARTHRITIS AND RHEUMATISM (2011)
Comparison of Cardiovascular Prognosis by 3 Serum Cystatin C Methods in the Heart and Soul Study
Michael G. Shlipak et al.
CLINICAL CHEMISTRY (2011)
Impact of Elevated Cystatin C Level on Cardiovascular Disease Risk in Predominantly High Cardiovascular Risk Populations A Meta-Analysis
Meng Lee et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Cystatin C and Long-Term Mortality Among Subjects With Normal Creatinine-Based Estimated Glomerular Filtration Rates
Cho-Kai Wu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort
M. Petri
LUPUS (2010)
Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients
M. A. Rabbani et al.
LUPUS (2009)
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
Johanna Gustafsson et al.
ARTHRITIS RESEARCH & THERAPY (2009)
C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis
Amy H. Kao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus
Murray B. Urowitz et al.
JOURNAL OF RHEUMATOLOGY (2008)
Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus
E. Svenungsson et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Cystatin C and estimates of renal function: Searching for a better measure of kidney function in diabetic patients
Laura Pucci et al.
CLINICAL CHEMISTRY (2007)
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study
C. R. Keller et al.
KIDNEY INTERNATIONAL (2007)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
Long-term prognosis and causes of death in systemic lupus erythematosus
Andrea Doria et al.
AMERICAN JOURNAL OF MEDICINE (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus
K. de Leeuw et al.
LUPUS (2006)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) -: XXIII.: Baseline predictors of vascular events
SMA Toloza et al.
ARTHRITIS AND RHEUMATISM (2004)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
MJ Roman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus
K Manger et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades
KE Moss et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
CY Hsu et al.
KIDNEY INTERNATIONAL (2002)
Risk factors for cardiovascular disease in systemic lupus erythematosus
E Svenungsson et al.
CIRCULATION (2001)
Share Paper
